Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ: VRTX )

332.58 +7.93 (+2.44%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 8, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,447,185
Open 324.00
Bid (Size) 333.00 (1)
Ask (Size) 338.46 (1)
Prev. Close 324.65
Today's Range 323.02 - 334.07
52wk Range 243.17 - 354.46
Shares Outstanding 259,428,394
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
FDA Accepts Biologics License Applications for exagamglogene autotemcel (exa-cel) for Severe Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia
From Vertex Pharmaceuticals Incorporated
Via Business Wire
5 Top Stocks to Buy in June
There are always buying opportunities in the stock market. 
Via The Motley Fool

Performance

YTD
+16.28%
+16.28%
1 Month
-3.55%
-3.55%
3 Month
+15.93%
+15.93%
6 Month
+3.50%
+3.50%
1 Year
+21.14%
+21.14%

More News

Read More
Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?
Via The Motley Fool
$1000 Invested In This Stock 15 Years Ago Would Be Worth $10,000 Today
Via Benzinga
CRISPR Therapeutics: A Galaxy's Worth of Deep Value
Via The Motley Fool
Expert Ratings for Vertex Pharmaceuticals
Via Benzinga
$100 Invested In Vertex Pharmaceuticals 20 Years Ago Would Be Worth This Much Today
Via Benzinga
A New S&P 500 Bull Market Is Nearly Here: 3 No-Brainer Stocks to Buy Sooner Rather Than Later
Via The Motley Fool
3 Top Healthcare Stocks to Buy for June
Via The Motley Fool
Wall Street Says This Growth Stock Is a Buy, but Is It Overvalued?
Via The Motley Fool
Want $1 Million in Retirement? Invest $250,000 in These 3 Stocks and Wait a Decade
Via The Motley Fool
Got $1,000? 2 Amazing Growth Stocks That Could Help You Retire Richer
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For May 30, 2023
Via Benzinga
Vertex to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference on June 13
From Vertex Pharmaceuticals Incorporated
Via Business Wire
Wall Street Thinks This Stock Will Only Rise 12%: Here's Why It Could Jump a Lot More
Via The Motley Fool
Want to Get Richer? 3 Top Stocks to Buy Now and Hold Forever
Via The Motley Fool
The Best Stocks to Invest $20,000 in Right Now
Via The Motley Fool
2 Supercharged Stocks to Buy With $100
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
2 Biotech Stocks That Could Help Set You Up for Life
Via The Motley Fool
Gilead Sciences Stock Reaches 80-Plus Relative Strength Rating Benchmark
Via Investor's Business Daily
2 Top Trends to Invest $5,000 in Right Now
Via The Motley Fool
Better Growth Stock: CRISPR Therapeutics vs. Teladoc Health
Via The Motley Fool
Ionis Pharmaceuticals Stock Sees IBD RS Rating Climb To 79
Via Investor's Business Daily
2 Hot Stocks to Buy and Hold Until You Retire
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.